This study evaluates the effect of percutaneous electrical nerve stimulation (PENS) and transcutaneous nerve stimulation (TENS) for pain relieving in patients with liver cancer. Patients will randomly allocated into PENS group, Tens group and control group.
PENS and TENS have been reported with analgesic effect in patients with pain, including cancer pain, lower back pain, neck pain, stomachache and so on. Effect and mechanism of PENS on pain relieving has been widely researched. With additional electrical stimulation in certain frequency and intensity to conventional acupuncture, pain controlling effect has been largely enhanced. However, invasive operation limits its application and acceptability, especially on pancreatic cancer. TENS is an advanced technique generated from PENS, which is much more welcome for its noninvasive character. Further more, its analgesic effect on cancer pain has been proved by several multi-central, randomized, clinical trials.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
36
Fuda Cancer Hospital
Guangzhou, Guangdong, China
pain score
pain score assessed via visual analogue scale (VAS)
Time frame: day0 to day6
quantity of analgesic medication
decreasing in quantity of analgesic medication
Time frame: day0 to Day6
times of breakthrough pain (BTP)
times of BTP per day
Time frame: day0 to day6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.